Skip to main content
Log in

MEG3 alleviates ankylosing spondylitis by suppressing osteogenic differentiation of mesenchymal stem cells through regulating microRNA-125a-5p-mediated TNFAIP3

  • Published:
Apoptosis Aims and scope Submit manuscript

Abstract

Osteoblasts are important regulators of bone formation, but their roles in ankylosing spondylitis (AS) remain unclear. This study aims to explore the role of long non-coding RNA (lncRNA) maternally expressed 3 (MEG3) MEG3 in AS. Serum from AS patients as well as AS mesenchymal stem cells (ASMSCs) and healthy donors mesenchymal stem cells (HDMSCs) was collected. Accordingly, poorly expressed MEG3 and TNF alpha induced protein 3 (TNFAIP3) as well as overexpressed microRNA-125a-5p (miR-125a-5p) were noted in the serum of AS patients and in ASMSCs during the osteogenic induction process. Meanwhile, the interaction among MEG3, miR-125a-5p, and TNFAIP3 was determined and their effect on osteoblast activity was examined in vitro and in vivo. Overexpression of MEG3 and TNFAIP3 or inhibition of miR-125a-5p was found to inactivate the Wnt/β-catenin pathway, thus suppressing osteogenic differentiation of MSCs. MEG3 competitively bound to miR-125a-5p to increase TNFAIP3 expression, thereby inactivating the Wnt/β-catenin pathway and repressing the osteogenic differentiation of MSCs. In proteoglycan (PG)-induced AS mouse models, MEG3 also reduced osteogenic activity of MSCs to inhibit AS progression through the miR-125a-5p/TNFAIP3/Wnt/β-catenin axis. Therefore, up-regulation of MEG3 or depletion of miR-125a-5p holds potential of alleviating AS, which sheds light on a new therapeutic strategy for AS treatment.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8
Fig. 9
Fig. 10

Similar content being viewed by others

Data availability

The datasets generated/analysed during the current study are available from the corresponding author on reasonable request.

Abbreviations

AS:

Ankylosing spondylitis

lncRNA:

Long non-coding RNA

MEG3:

Maternally expressed 3

ASMSCs:

AS mesenchymal stem cells

HDMSCs:

Healthy donors mesenchymal stem cells

miR-125a-5p:

microRNA-125a-5p

TNFAIP3:

TNF alpha induced protein 3

GM:

Growth medium

ALP:

Alkaline phosphatase

RIPA:

Radio-immunoprecipitation assay

CST:

Cell signaling technologies

IHC:

Immunohistochemistry

DAB:

Diaminobenzidine

References

  1. Tam LS, Gu J, Yu D (2010) Pathogenesis of ankylosing spondylitis. Nat Rev Rheumatol 6(7):399–405

    Article  PubMed  Google Scholar 

  2. Xie Z, Wang P, Li Y, Deng W, Zhang X, Su H, Li D, Wu Y, Shen H (2016) Imbalance between bone morphogenetic protein 2 and noggin induces abnormal osteogenic differentiation of mesenchymal stem cells in ankylosing spondylitis. Arthritis Rheumatol 68(2):430–440

    Article  CAS  PubMed  Google Scholar 

  3. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 68(6):394–424

    Article  PubMed  Google Scholar 

  4. Zhang W, Dong R, Diao S, Du J, Fan Z, Wang F (2017) Differential long noncoding RNA/mRNA expression profiling and functional network analysis during osteogenic differentiation of human bone marrow mesenchymal stem cells. Stem Cell Res Ther 8(1):30

    Article  PubMed Central  PubMed  Google Scholar 

  5. Liu W, Huang L, Zhang C, Liu Z (2019) lncRNA MEG3 is downregulated in ankylosing spondylitis and associated with disease activity, hospitalization time and disease duration. Exp Ther Med 17(1):291–297

    CAS  PubMed  Google Scholar 

  6. Wang Q, Li Y, Zhang Y, Ma L, Lin L, Meng J, Jiang L, Wang L, Zhou P, Zhang Y (2017) LncRNA MEG3 inhibited osteogenic differentiation of bone marrow mesenchymal stem cells from postmenopausal osteoporosis by targeting miR-133a-3p. Biomed Pharmacother 89:1178–1186

    Article  CAS  PubMed  Google Scholar 

  7. Perez-Sanchez C, Font-Ugalde P, Ruiz-Limon P, Lopez-Pedrera C, Castro-Villegas MC, Abalos-Aguilera MC, Barbarroja N, Arias-de la Rosa I, Lopez-Montilla MD, Escudero-Contreras A, Lopez-Medina C, Collantes-Estevez E, Jimenez-Gomez Y (2018) Circulating microRNAs as potential biomarkers of disease activity and structural damage in ankylosing spondylitis patients. Hum Mol Genet 27(5):875–890

    Article  CAS  PubMed  Google Scholar 

  8. Liu CY, Zhang YH, Li RB, Zhou LY, An T, Zhang RC, Zhai M, Huang Y, Yan KW, Dong YH, Ponnusamy M, Shan C, Xu S, Wang Q, Zhang YH, Zhang J, Wang K (2018) LncRNA CAIF inhibits autophagy and attenuates myocardial infarction by blocking p53-mediated myocardin transcription. Nat Commun 9(1):29

    Article  PubMed Central  PubMed  Google Scholar 

  9. Nakamura BN, Glazier A, Kattah MG, Duong B, Jia Y, Campo D, Shao L (2018) A20 regulates canonical wnt-signaling through an interaction with RIPK4. PLoS ONE 13(5):e0195893

    Article  PubMed Central  PubMed  Google Scholar 

  10. Klingberg E, Nurkkala M, Carlsten H, Forsblad-d’Elia H (2014) Biomarkers of bone metabolism in ankylosing spondylitis in relation to osteoproliferation and osteoporosis. J Rheumatol 41(7):1349–1356

    Article  PubMed  Google Scholar 

  11. Zhang F, Cao K, Du G, Zhang Q, Yin Z (2019) miR-29a promotes osteoblast proliferation by downregulating DKK-1 expression and activating Wnt/beta-catenin signaling pathway. Adv Clin Exp Med 28(10):1293–1300

    Article  PubMed  Google Scholar 

  12. van der Linden S, Valkenburg HA, Cats A (1984) Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum 27(4):361–368

    Article  PubMed  Google Scholar 

  13. Liu CH, Raj S, Chen CH, Hung KH, Chou CT, Chen IH, Chien JT, Lin IY, Yang SY, Angata T, Tsai WC, Wei JC, Tzeng IS, Hung SC, Lin KI (2019) HLA-B27-mediated activation of TNAP phosphatase promotes pathogenic syndesmophyte formation in ankylosing spondylitis. J Clin Invest 129(12):5357–5373

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  14. Shi Y, Liu B, Wang CS, Yang CS (2018) MST1 down-regulation in decreasing apoptosis of aortic dissection smooth muscle cell apoptosis. Eur Rev Med Pharmacol Sci 22(7):2044–2051

    CAS  PubMed  Google Scholar 

  15. Geng Y, Chen J, Alahdal M, Chang C, Duan L, Zhu W, Mou L, Xiong J, Wang M, Wang D (2020) Intra-articular injection of hUC-MSCs expressing miR-140-5p induces cartilage self-repairing in the rat osteoarthritis. J Bone Miner Metab 38(3):277–288

    Article  CAS  PubMed  Google Scholar 

  16. Shen H, Cui G, Li Y, Ye W, Sun Y, Zhang Z, Li J, Xu G, Zeng X, Zhang Y, Zhang W, Huang Z, Chen W, Shen Z (2019) Follistatin-like 1 protects mesenchymal stem cells from hypoxic damage and enhances their therapeutic efficacy in a mouse myocardial infarction model. Stem Cell Res Ther 10(1):17

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  17. Ma S, Wang DD, Ma CY, Zhang YD (2019) microRNA-96 promotes osteoblast differentiation and bone formation in ankylosing spondylitis mice through activating the Wnt signaling pathway by binding to SOST. J Cell Biochem 120(9):15429–15442

    Article  CAS  PubMed  Google Scholar 

  18. Yang C, Ding P, Wang Q, Zhang L, Zhang X, Zhao J, Xu E, Wang N, Chen J, Yang G, Hu W, Zhou X (2016) Inhibition of complement retards ankylosing spondylitis progression. Sci Rep 6:34643

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  19. Li JQ, Hu SY, Wang ZY, Lin J, Jian S, Dong YC, Wu XF, Dai L, Cao LJ (2016) Long non-coding RNA MEG3 inhibits microRNA-125a-5p expression and induces immune imbalance of Treg/Th17 in immune thrombocytopenic purpura. Biomed Pharmacother 83:905–911

    Article  CAS  PubMed  Google Scholar 

  20. Sun H, Peng G, Wu H, Liu M, Mao G, Ning X, Yang H, Deng J (2020) Long non-coding RNA MEG3 is involved in osteogenic differentiation and bone diseases (Review). Biomed Rep 13(1):15–21

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  21. Gong Y, Xu F, Zhang L, Qian Y, Chen J, Huang H, Yu Y (2014) MicroRNA expression signature for Satb2-induced osteogenic differentiation in bone marrow stromal cells. Mol Cell Biochem 387(1–2):227–239

    Article  CAS  PubMed  Google Scholar 

  22. Jo S, Han J, Lee YL, Yoon S, Lee J, Wang SE, Kim TH (2019) Regulation of osteoblasts by alkaline phosphatase in ankylosing spondylitis. Int J Rheum Dis 22(2):252–261

    Article  CAS  PubMed  Google Scholar 

  23. Yang M, Zhou Y, Liu L, Wang S, Jiang J, Shang Q, Yu H, Xiang X, Pang X, Li T, Zhao P (2019) Decreased A20 expression on circulating CD56(bright) NK cells contributes to a worse disease status in patients with ankylosing spondylitis. Clin Exp Immunol 198(1):1–10

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  24. Feng Z, Zhai Y, Zheng Z, Yang L, Luo X, Dong X, Han Q, Jin J, Chen ZN, Zhu P (2018) Loss of A20 in BM-MSCs regulates the Th17/Treg balance in Rheumatoid Arthritis. Sci Rep 8(1):427

    Article  PubMed Central  PubMed  Google Scholar 

  25. Dang RJ, Yang YM, Zhang L, Cui DC, Hong B, Li P, Lin Q, Wang Y, Wang QY, Xiao F, Mao N, Wang C, Jiang XX, Wen N (2016) A20 plays a critical role in the immunoregulatory function of mesenchymal stem cells. J Cell Mol Med 20(8):1550–1560

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  26. Graff JW, Dickson AM, Clay G, McCaffrey AP, Wilson ME (2012) Identifying functional microRNAs in macrophages with polarized phenotypes. J Biol Chem 287(26):21816–21825

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  27. Chen H, Chen L (2020) An integrated analysis of the competing endogenous RNA network and co-expression network revealed seven hub long non-coding RNAs in osteoarthritis. Bone Joint Res 9(3):90–98

    Article  PubMed Central  PubMed  Google Scholar 

  28. Chen K, Ma Y, Wu S, Zhuang Y, Liu X, Lv L, Zhang G (2019) Construction and analysis of a lncRNAmiRNAmRNA network based on competitive endogenous RNA reveals functional lncRNAs in diabetic cardiomyopathy. Mol Med Rep 20(2):1393–1403

    CAS  PubMed  Google Scholar 

  29. Fan FY, Deng R, Qiu L, Wen Q, Zeng Y, Gao L, Zhang C, Kong P, Zhong J, Zeng N, Li Z, Su Y, Zhang X (2019) miR-203a-3p.1 is involved in the regulation of osteogenic differentiation by directly targeting Smad9 in MM-MSCs. Oncol Lett 18(6):6339–6346

    CAS  PubMed Central  PubMed  Google Scholar 

  30. Wu H, Cao F, Zhou W, Wang G, Liu G, Xia T, Liu M, Mi B, Liu Y (2020) Long noncoding RNA FAM83H-AS1 modulates SpA-inhibited osteogenic differentiation in human bone mesenchymal stem cells. Mol Cell Biol 40(5):e00362-e419

    Article  CAS  PubMed Central  PubMed  Google Scholar 

Download references

Acknowledgements

Not applicable.

Funding

This work was supported by the Youth Science Foundation of Guangxi Medical University, Grant/Award Number: GXMUYFY201712; Guangxi Young and Middle aged Teacher’s Basic Ability Promoting Project, Grant/Award Number: 2019KY0119.

Author information

Authors and Affiliations

Authors

Contributions

CL and TL designed study and collated data, ZZ and JC carried out data analyses and produced initial draft of manuscript, JX, XZ and LR contributed to drafting manuscript. All authors read and approved final manuscript.

Corresponding authors

Correspondence to Xinli Zhan or Liang Ren.

Ethics declarations

Competing interests

The authors declare that they have no competing interests.

Ethical approval

All research procedures were approved by the Ethics Committee of The First Affiliated Hospital of Guangxi Medical University and in line with the Declaration of Helsinki. All animal experiments were approved by the Animal Ethics Committee of The First Affiliated Hospital of Guangxi Medical University.

Informed consent

All participants and/or legal guardians signed the informed consents before experiments.

Consent for publication

Not applicable.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Below is the link to the electronic supplementary material.

10495_2022_1804_MOESM1_ESM.jpg

Supplementary file1 (JPG 254 kb). Fig. S1 Chondrogenesis in pellet cultures. Cartilage beads formed by MSCs cultured under chondrogenic conditions for 1, 2 and 3 weeks with Alcian-blue staining

10495_2022_1804_MOESM2_ESM.jpg

Supplementary file2 (JPG 423 kb). Fig. S2 miR-125a-5p expression in ASMSCs and HDMSCs treated with LV- miR-125a-5p detected by RT-qPCR. ***p < 0.001. The measurement data were expressed as mean ± standard deviation, and data between two groups were compared with independent sample t test. The cell experiment was conducted in triplicates

10495_2022_1804_MOESM3_ESM.jpg

Supplementary file3 (JPG 8990 kb). Fig. S3 Differentially expressed mRNAs in AS samples screened by bioinformatics analyses. A, A heat map of the expression of the differentially expressed mRNAs in AS patient samples from the GSE11886 microarray. B, Volcano map of differentially expressed mRNAs in AS patient samples from the GSE11886 microarray. C, Veen diagram of the downstream target genes of miR-125a-5p predicted by starBase (http://starbase.sysu.edu.cn/index.php), TargetScan (http://www.targetscan.org/vert_71/), mirDIP (http://ophid.utoronto.ca/mirDIP/index.jsp#R) and miRDB (http://www.mirdb.org/) databases and the significantly down-regulated genes in the GSE11886 microarray. Blue circle indicates target genes predicted by starBase database, red circle indicates target genes predicted by TargetScan database, green circle indicates target genes predicted by mirDIP database, yellow circle indicates target genes predicted by miRDB database, orange circle indicates the significantly down-regulated genes in AS patient samples in GSE11886 microarray, and the middle part indicates the intersection of the target genes predicted by these five datasets

Supplementary file4 (DOCX 15 kb)

Supplementary file5 (DOCX 16 kb)

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Liu, C., Liang, T., Zhang, Z. et al. MEG3 alleviates ankylosing spondylitis by suppressing osteogenic differentiation of mesenchymal stem cells through regulating microRNA-125a-5p-mediated TNFAIP3. Apoptosis 28, 498–513 (2023). https://doi.org/10.1007/s10495-022-01804-2

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10495-022-01804-2

Keywords

Navigation